As of 10:07am ET
| -0.0001 / -0.02%|
The 1 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +654.72% increase from the last price of 0.66.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.